HDAC9 and uveal melanoma: Alterations in epigenetic regulations contribute to this phenotype, as evidenced by the restoration of melanocyte differentiation when uveal melanoma cells with mutated BAP1 are treated with histone deacetylase (HDAC) inhibitors (Figure 2C).